- Home
- COCH vs AIFF Comparison
COCH vs AIFF Comparison
Compare COCH & AIFF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COCH
- AIFF
- Stock Information
- Founded
- COCH 1995
- AIFF 2006
- Country
- COCH United States
- AIFF Canada
- Employees
- COCH N/A
- AIFF N/A
- Industry
- COCH Blank Checks
- AIFF
- Sector
- COCH Finance
- AIFF
- Exchange
- COCH Nasdaq
- AIFF NYSE
- Market Cap
- COCH 29.8M
- AIFF 26.6M
- IPO Year
- COCH N/A
- AIFF N/A
- Fundamental
- Price
- COCH $1.48
- AIFF $7.79
- Analyst Decision
- COCH Strong Buy
- AIFF
- Analyst Count
- COCH 3
- AIFF 0
- Target Price
- COCH $8.00
- AIFF N/A
- AVG Volume (30 Days)
- COCH 26.8K
- AIFF 18.1M
- Earning Date
- COCH 04-01-2025
- AIFF 03-04-2025
- Dividend Yield
- COCH N/A
- AIFF N/A
- EPS Growth
- COCH N/A
- AIFF N/A
- EPS
- COCH N/A
- AIFF N/A
- Revenue
- COCH $278,000.00
- AIFF $74,000.00
- Revenue This Year
- COCH N/A
- AIFF N/A
- Revenue Next Year
- COCH $19.76
- AIFF N/A
- P/E Ratio
- COCH N/A
- AIFF N/A
- Revenue Growth
- COCH 15.35
- AIFF N/A
- 52 Week Low
- COCH $1.17
- AIFF $1.86
- 52 Week High
- COCH $11.46
- AIFF $17.20
- Technical
- Relative Strength Index (RSI)
- COCH 45.07
- AIFF 55.76
- Support Level
- COCH $1.39
- AIFF $7.11
- Resistance Level
- COCH $1.62
- AIFF $17.20
- Average True Range (ATR)
- COCH 0.13
- AIFF 2.04
- MACD
- COCH 0.00
- AIFF 0.15
- Stochastic Oscillator
- COCH 31.03
- AIFF 33.45
About COCH Envoy Medical Inc.
Envoy Medical Inc is a hearing health company focused on providing innovative medical technologies. It is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and quality of life.
About AIFF FIREFLY NEUROSCIENCE INC
Firefly Neuroscience Inc is an AI company developing innovative neuroscientific solutions that improve outcomes for patients with mental illnesses and cognitive disorders. It is focused on the commercialization of its Brain Network Analytics (BNA) software platform (the "BNA Platform")and the discovery and clinical development of biomarkers that support better outcomes for people suffering from mental illnesses and cognitive disorders.